Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Pramlintide fda approval date?Combivent generic equivalent?Bivalirudin manufacturer?Antiox mebendazole price?Can i take anti histamine with statin?
Methotrexate, used for rheumatoid arthritis, psoriasis, and some cancers, can harm kidneys through direct toxicity, especially at high doses or with poor hydration. In elderly patients (over 65), risks rise due to reduced kidney function, lower muscle mass (affecting dosing), and frequent use of drugs like NSAIDs or diuretics that worsen dehydration or compete for kidney clearance.[1][2]
Age-related GFR decline (1-2 mL/min/year after 40) slows methotrexate excretion, prolonging exposure. Comorbidities like diabetes, hypertension, or heart failure affect 70% of elderly users, compounding damage. Studies show 2-3x higher AKI incidence vs. younger adults.[4][5]
In rheumatoid arthritis patients on low-dose methotrexate (7.5-25 mg/week), kidney issues hit 2-10% overall, but up to 15-25% in those over 75 with baseline GFR <60 mL/min. High-dose IV (for cancer) sees 20-40% AKI without prevention.[3][6]
Mild cases reverse with discontinuation and hydration; severe AKI may need dialysis (5-10% of affected elderly). Chronic use risks permanent GFR loss.[4] [1]: Lexicomp - Methotrexate Nephrotoxicity [2]: UpToDate - Methotrexate Drug Interactions and Toxicity [3]: American Journal of Kidney Diseases - Methotrexate-Associated AKI in Rheumatology (2018) [4]: Journal of Rheumatology - Renal Toxicity in Elderly RA Patients on MTX (2020) [5]: FDA Label - Methotrexate (Rheumatrex) [6]: Clinical Pharmacology & Therapeutics - Age-Related MTX Clearance (2019)
Other Questions About Common :